NFKB1 and osteoarthritis: In summary, our results suggest that HA and CS, alone or in combination, effectively suppress the NF-κB pathway, slow down the process of ECM degradation in cartilage tissue, and slow down the progression of osteoarthritis in rats, which further provides a possible therapeutic option for osteoarthritis.